Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 187

1.

[Inevitable senile death].

Saksela E.

Duodecim. 2014;130(18):1843-50. Review. Finnish.

PMID:
25558626
2.

Perimän vauuriot, vanheneminen ja syöpä--erottamaton kolmikko. .

Laiho M, Saksela E.

Duodecim. 2007;123(13):1535-6. Finnish. No abstract available.

PMID:
17727144
3.

TOP2A and HER2 gene amplification as predictors of response to anthracycline treatment in breast cancer.

Villman K, Sjöström J, Heikkilä R, Hultborn R, Malmström P, Bengtsson NO, Söderberg M, Saksela E, Blomqvist C.

Acta Oncol. 2006;45(5):590-6.

PMID:
16864174
4.

[Cancer is a souvenir from the RNA world].

Saksela E.

Duodecim. 2005;121(2):132-3. Finnish. No abstract available.

PMID:
15745351
5.

[New drugs for cancer treatment].

Saksela E.

Duodecim. 2004;120(10):1185-7. Finnish. No abstract available.

PMID:
15232974
6.

Consistency of staining and reporting of oestrogen receptor immunocytochemistry within the European Union--an inter-laboratory study.

Wells CA, Sloane JP, Coleman D, Munt C, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, Bussolati G, Connolly CE, Dervan P, Drijkoningen M, Ellis IO, Elston CW, Eusebi V, Faverly D, Heikkila P, Holland R, Jacquemier J, Lacerda M, Martinez-Penuela J, De Miguel C, Peterse JL, Rank F, Reiner A, Saksela E, Sigal-Zafrani B, Sylvan M, Borisch B, Cserni G, Decker T, Kerner H, Kulka J, Regitnig P, Sapino A, Tanous AM, Thorstenson S, Zozaya E; European Working Group for Breast Screening Pathology.

Virchows Arch. 2004 Aug;445(2):119-28. Epub 2004 Jun 24.

PMID:
15221370
7.

[Is death biologically inevitable?].

Saksela E.

Duodecim. 2003;119(13):1245-53. Review. Finnish. No abstract available.

PMID:
12908188
8.

[Matti Ayräpää Award to Matti Haltia].

Saksela E.

Duodecim. 2002;118(1):13-4. Finnish. No abstract available.

PMID:
12228991
9.

Tumour microvessel density as predictor of chemotherapy response in breast cancer patients.

Tynninen O, Sjöström J, von Boguslawski K, Bengtsson NO, Heikkilä R, Malmström P, Ostenstad B, Wist E, Valvere V, Saksela E, Paavonen T, Blomqvist C.

Br J Cancer. 2002 Jun 17;86(12):1905-8.

10.

The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer.

Sjöström J, Blomqvist C, von Boguslawski K, Bengtsson NO, Mjaaland I, Malmström P, Ostenstadt B, Wist E, Valvere V, Takayama S, Reed JC, Saksela E.

Clin Cancer Res. 2002 Mar;8(3):811-6.

11.

C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer.

Sjöström J, Collan J, von Boguslawski K, Franssila K, Bengtsson NO, Mjaaland I, Malmström P, Østenstad B, Wist E, Valvere V, Bergh J, Skiöld-Petterson D, Saksela E, Blomqvist C.

Eur J Cancer. 2002 Mar;38(4):535-42.

PMID:
11872346
12.

Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer.

Sjöström J, Blomqvist C, Heikkilä P, Boguslawski KV, Räisänen-Sokolowski A, Bengtsson NO, Mjaaland I, Malmström P, Ostenstadt B, Bergh J, Wist E, Valvere V, Saksela E.

Clin Cancer Res. 2000 Aug;6(8):3103-10.

13.

c-Myc and E1A induced cellular sensitivity to activated NK cells involves cytotoxic granules as death effectors.

Klefstrom J, Kovanen PE, Somersalo K, Hueber AO, Littlewood T, Evan GI, Greenberg AH, Saksela E, Timonen T, Alitalo K.

Oncogene. 1999 Apr 1;18(13):2181-8.

14.

A guinea pig's view on prostate cancer screening trials.

Saksela E.

Acta Oncol. 1998;37(6):533-7. No abstract available.

PMID:
9860310
15.

Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation.

Klefstrom J, Arighi E, Littlewood T, Jäättelä M, Saksela E, Evan GI, Alitalo K.

EMBO J. 1997 Dec 15;16(24):7382-92.

16.

[Prostate cancer screening].

Saksela E.

Duodecim. 1997;113(9):871. Finnish. No abstract available.

PMID:
11466912
17.

[Joint pains, neurological symptoms and hypergammaglobulinemia].

Naukkarinen V, Saksela E.

Duodecim. 1997;113(9):853-60. Finnish. No abstract available.

PMID:
11466907
18.

[Prostate cancer and medical ethics].

Saksela E.

Duodecim. 1997;113(6):532-6; author reply 536-9. Finnish. No abstract available.

PMID:
11370075
19.

[New immunological dimensions of apoptosis].

Saksela E.

Duodecim. 1997;113(16):1579-83. Review. Finnish. No abstract available.

PMID:
10650624
20.

[An eye for morphology in the medical profession].

Saksela E.

Duodecim. 1997;113(14):1403-6. Finnish. No abstract available.

PMID:
10622149

Supplemental Content

Loading ...
Support Center